| Financial Year |
March 31 2023 |
| Monetary Funds |
3,662,345,641.73 |
| Held-for-trading Financial Assets |
64,600,000.00 |
| Notes Receivable |
19,593,967.15 |
| Accounts Receivable |
191,626,286.36 |
| Advances to Suppliers |
13,520,179.30 |
| Other Receivables |
7,828,810.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
425,082.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,364,255.61 |
| Total Current Assets |
4,386,679,348.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
107,714,549.75 |
| Investment Properties |
-- |
| Fixed Assetes |
123,601,208.65 |
| Under-construction Projects |
2,863,313.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,139,102.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
606,151.67 |
| Deferred Income Tax Assets |
1,052,001.66 |
| Other Non-Current Assets |
16,713,383.63 |
| Sub-Total of Non-Current Assets |
431,616,141.92 |
| Total Assets |
4,818,295,490.09 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,001,157,949.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,297,824.80 |
| Taxes Payable |
15,642,743.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
784,329.12 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,333,648.85 |
| Other Current Liabilities |
26,506,422.92 |
| Sub-Total of Current Liabilities |
1,139,913,843.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
50,000.00 |
| Deferred Income Tax Liabilities |
2,908,041.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
28,536,021.67 |
| Total Liabilities |
1,168,449,864.71 |
| Paid-In Capital(Or Share Stock) |
231,058,146.00 |
| Capital Surplus |
1,257,829,329.49 |
| Surplus Reserve |
115,529,073.00 |
| LESS:Treasury Stock |
95,349,751.59 |
| Undistributed Profits |
2,121,583,932.02 |
| Minority Stockholder's Interest |
10,594,517.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,639,251,108.33 |
| Owner's Equity（Stockholder's Equity） |
3,649,845,625.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,818,295,490.09 |
